V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This is an 18 week (2 weeks run-in, 16 weeks double blind) trial, to determine if an
antiviral drug, valacyclovir (Valtrex) is helpful in treating the symptoms of psychosis, a
form of a mental disorder.